Skip to content
OpenCapital
Get started

MIRA Pharmaceuticals, Inc. MIRA Q3 2025 earnings

Reported November 13, 2025 · Before market open

EPS-$1.18In line
EPS estimate-$1.18

Next report

Sep 2, 2026 (in a month)

Versus estimates

Revenue

Q4 2024$11.2M

Diluted EPS

Q1 2026-$0.03Q4 2025-$0.15Miss by $0.11
Q3 2025-$1.18In line
Q2 2025-$0.09Beat by $0.02Q1 2025-$0.11Beat by $0.04Q4 2024-$0.15Beat by $0.14

Ask the moment MIRA Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MIRA Pharmaceuticals, Inc. report Q3 2025 earnings?
MIRA Pharmaceuticals, Inc. (MIRA) reported Q3 2025 earnings on November 13, 2025 before market open.
What were MIRA Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
MIRA Pharmaceuticals, Inc. reported eps of $-1.18 for Q3 2025.
Did MIRA Pharmaceuticals, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-1.18 by $0.00.
How did MIRA Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 742.9% from $-0.14.
Where can I find MIRA Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001493152-25-022112) directly on SEC EDGAR. The filing index links above go to sec.gov.